Items with tag "startup"

News

Confo Therapeutics is awarded a EUR 1M grant to increase its screening capabilities

Confo Therapeutics announced today that it has received a €1 million grant from the Flemish Government through Flanders Innovation & Entrepreneurship (VLAIO). The grant will be used to support the…

Read more

UgenTec receives €50.000 grant by European Union

Under guidance of MINT, the Belgian PCR automation software company is one out of two Belgian companies to be granted and part of 36 grantees amongst 507 requests. UgenTec, the Belgian PCR aut…

Read more

Delphi Genetics receives GMP accreditation for plasmid DNA bioproduction

Genetic engineering specialist Delphi Genetics announced that it has received the certificate of Good Manufacturing Practice (GMP) for plasmid DNA production. The GMP productions will be realized …

Read more

Free business training for biobased startups

The BioBase4SME project, co-financed by Europe’s Interreg NWE programme, is now providing start-up companies working in the bioeconomy with €7,000 worth of specialist training, fully funded by the…

Read more

ProDigest starts collaboration with US university

ProDigest, which develops unique laboratory models of the complete gastrointestinal tract of humans and animals, and the New Jersey Institute for Food, Nutrition, and Health (IFNH) at Rutgers Univ…

Read more

Galapagos: Company of the Year

The Mechelen-based Galapagos received yesterday in New York the award for company of the year by the Belgian-American Chamber of Commerce, Belcham. This happened at the annual gala of the organiza…

Read more

Essenscia/bio.be organizes Dermira and JLABS visits during Bio US!

Today, in parallel with the Bio International Convention in San Fransisco, essenscia / bio.be organizes two company visits in California together with Minister of Social Affairs and Public Health,…

Read more

Johnson & Johnson presents its new incubator JLINX, located at the Janssen Campus in Belgium

Johnson & Johnson Innovation is expanding its company incubation strategy to include a new multifaceted initiative in Europe designed to identify and nurture early-stage companies actively pursuin…

Read more

New spin-off AmplyCell to boost antibody production

AmplyCell is the first spin-off from the College of the Province of Liege. This service company has developed an innovative advanced technology, based on "cellular fitness". The technology allows …

Read more

2 million euros for animal scanner

The Belgian startup Molecubes received 1.9 million euro from different investors for the commercialization of a compact scanner for animals. Molecubes, a spin-off from the University of Ghent…

Read more

Device for 3D hologram images of cells

Ovizio, launched in 2009 as spin-off from the ULB, develops ultra specialized microscopes allowing creation of a hologram-like 3D image of biological cells. The device is ideal to follow up on the…

Read more

bio2clean, new spin-off for green soil remediation

Hasselt University has a new spin-off, 'bio2clean', for phytoremediation, using plants to clean up soils and (ground) water. With this startup, the Centre for Environmental Sciences (CMK) wants to…

Read more

New biodegradable gauze for better wound healing

Researchers from the universities of Hasselt, Liege, Aachen and Maastricht developed new 'plastics' that are biodegradable by the body and which could replace the traditional gauze bandage for wou…

Read more

Do you need more lab space?

Finding the right location for a Life Sciences company can be a big challenge. Moreover, a company might have special needs for its infrastructure. Many lab facilities are currently vacant, while …

Read more

Prof. Carmeliet as Chief Scientific Strategy Advisor at Oncurious

Oncurious NV, an oncology company focused on the development of innovative medicines for the treatment of pediatric tumors, today announces the appointment of Prof Dr Peter Carmeliet as its Chief …

Read more

New kid on the biotech block: Confo Therapeutics

Confo Therapeutics, is the new spin-off of VIB and Vrije Universiteit Brussel. A consortium led by Capricorn Health-Tech Fund with the participation of Qbic and SOFI contributed € 3 million in the…

Read more

Soldier flies for waste treatment

In 2012, Johan Jacobs quit his job as a diplomat to start a green waste management company named Millibeter. He ecologically treats biological waste by culturing soldier flies on it. The flies con…

Read more

Government incentives financially benefit startups

The Cabinet has set the fiscal conditions concerning tax shelters and crowdfunding for start-ups. The government wants to give start-ups a helping hand with these incentives. Although the regulati…

Read more

New biotech incubator in Ghent

Rudi Mariën, founder of former Innogenetics, and investor in multiple Flemish biotech companies and projects, is building a new business center which can house up to a dozen biotech startups “The …

Read more

Trinean wins 25.000 euro for disposables production

Trinean won the “Time for a Boost 2015” competition organized by Test and Measurement Solutions. CEO Kurt Hensen handed a cheque of 25 000 euro to the Ghent University spin-off. Trinean develo…

Read more

ThromboGenics and VIB found oncology company

Oncurious is a new oncology company that will perform clinical trials for the development of TB-403. This compound is a new promising agent for the treatment of brain tumors in children. Alongs…

Read more

Better decision making with VIGOR

The VIGOR Unit, a new spin-off of the University of Ghent, will help business leaders and policy makers take effective decisions on the basis of scientific insights and data. The focus of the foun…

Read more

Insights

Battling antibiotic resistance: a new protein powered solution

Battling antibiotic resistance: a new protein powered solution

The discovery of antibiotics fundamentally changed healthcare in the 20th century. Deadly infections suddenly became treatable and millions of lives were saved. But excessive antibiotic use in bot…

Read more

Microbiome regulations from an EU start-up's perspective

Microbiome regulations from an EU start-up's perspective

Interested in the microbiome? So are we! Here’s a sneak-peek into S-Biomedic, one of the first microbiome start-ups in Belgium. We asked her to tell us about the challenge of being a new company d…

Read more

Increase feeding success with VIPUN Medical’s new technology

Increase feeding success with VIPUN Medical’s new technology

Critically ill patients are often fed through nasogastric tubes. It is however hard for physicians to know if the stomach of these patients is working properly, which is important to know, as over…

Read more

TrinCE transfection wins pitch awards

TrinCE transfection wins pitch awards

The pitching session at Knowledge for Growth 2018 gave a select number of start-ups a chance to present their company to a top panel of potential investors. The winner of this year’s pitch awards …

Read more

CD3 as co-creator of drugs with academia and pharma

CD3 as co-creator of drugs with academia and pharma

The Center for Drug Design and Discovery (CD3), based in Leuven, bridges the gap between innovative biomedical research emerging from academic institutions or SMEs and pharmaceutical companies. Th…

Read more

Leveraging terabytes of single cell data

Leveraging terabytes of single cell data

Yvan Saeys is a young professor at VIB-UGent. As the group leader of the department of Data Mining and Modeling for Biomedicine he focuses on developing computational models for single cell analys…

Read more

Imaging beta-cells for better diabetes treatment

Imaging beta-cells for better diabetes treatment

One in eleven adults around the world has diabetes, according to figures published by the International Diabetes Federation (IDF) in 2017. A research team, led by Professor Decio L. Eizirik (ULB C…

Read more

After Ablynx, is an acquisition of Galapagos next?

After Ablynx, is an acquisition of Galapagos next?

The Gent biotech company Ablynx has been acquired by pharmaceutical giant Sanofi for 3.9 billion euros. The French Sanofi beat the Danish company Novo Nordisk to the deal after a much higher offer…

Read more

Diagnosing rare genetic conditions within minutes

Diagnosing rare genetic conditions within minutes

Moon is a new software package that, within minutes, diagnoses patients who suffer from rare diseases. All the software requires are the patient’s symptoms and sequencing data. Moon then applies a…

Read more

MyCartis barcodes biological samples

MyCartis barcodes biological samples

MyCartis is an early-stage company that was founded in September 2014 when Pronota (Ghent, Belgium) and the Biocartis Evalution Business unit (Lausanne, Switzerland) joined forces.  This was an id…

Read more

Watch Liège becoming a major healthcare hub

Watch Liège becoming a major healthcare hub

Bridge 2 Health (B2H), previously known as sCINNAMIC, is a company whose mission  is to valorize biomedical research from the University of Liège (ULg) and the Liège University Hospital (CHU de Li…

Read more

From Belgium to NYC and starting a 'super sniffer’ company

From Belgium to NYC and starting a 'super sniffer’ company

Charlotte D’Hulst left Belgium for a postdoc in NYC. Today she has two kids and lives in Brooklyn. Oh, and she founded a biotech company, MouSensor, LLC. Hard to resist the entrepreneurial buzz in…

Read more

Successful valorization of innovation: Paul Van Dun and Leuven R&D

Successful valorization of innovation: Paul Van Dun and Leuven R&D

Universities are a rich source of innovative ideas and discoveries, but the process of bringing them into the commercial realm is far from self-evident. When scientist-entrepreneurs need help sett…

Read more

Digestion in a jar - Time to SHIME®

Digestion in a jar - Time to SHIME®

In 2008, UGent spin-off ProDigest opened its doors. The company was built around a machine called the SHIME®, an in vitro model for the entire human gastrointestinal tract, complete with stomach a…

Read more

Novosides hits the sweet spot of glycoside synthesis

Novosides hits the sweet spot of glycoside synthesis

Linking a sugar moiety to small molecules alters their physicochemical properties, which can lead to a myriad of interesting applications. However, glycoside synthesis is no child’s play and was d…

Read more

A sneak-peak into the future of life sciences

A sneak-peak into the future of life sciences

In Belgium there is a high concentration of bio-pharmaceutical companies, together with excellent research centers and universities. This is a unique and an important driver of innovation and has …

Read more

Human milk from the incubator

Human milk from the incubator

Breastfeeding is beneficial for a newborn and is strongly advised to future moms. Still, for various reasons, breastfeeding is sometimes impossible, causing the baby to feed on infant formula. The…

Read more

VC Views

Why start-ups can become mega companies in the pharma sector

Why start-ups can become mega companies in the pharma sector

In a previous BioVox article, we analyzed the steps needed for a life sciences start-up to turn into a fully integrated, commercial stage biotech company. For this to happen, the hurdles that need…

Read more

How to build a “European Amgen”

How to build a “European Amgen”

There are still very few large European biotech companies to compete with the Amgens and Gileads of the world.  Only a handful of European biotech companies have managed to stay independent, grow,…

Read more

Belgium vs Germany in the Life Sciences start-up championship

Belgium vs Germany in the Life Sciences start-up championship

Germany is one of the leading industrial nations in the world and has 8x more inhabitants than Belgium. However, when it comes to investments in early startups and early stage funds in life scienc…

Read more

How Aphea.Bio managed to gather the funds to transcend from academia to industry

How Aphea.Bio managed to gather the funds to transcend from academia to industry

Aphea.Bio is an agriculture startup, originating from the VIB and flourishing underneath the wings of V-Bio Ventures. Steven Vandenabeele (CTO at Aphea.Bio and previously working at BASF-CropDesig…

Read more

The leap from academia to industry

The leap from academia to industry

The earlier in development, the greater the risk. It’s an unspoken law in biotech that makes valorizing promising academic projects difficult to fund. Venture Capitalists (VCs) specialized in earl…

Read more

Confo Therapeutics: Drugging the Undruggable

Confo Therapeutics: Drugging the Undruggable

Llama single-domain antibodies have found yet another application, one that Confo Therapeutics is fully exploiting. Ablynx is developing Nanobodies®, AgroSavfe focuses on Agrobodies®, and Confo wi…

Read more

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

GSK KU Leuven Itera Life Science Turnstone XpandInnovation UGent Biowin Flanders.bio V-Bio Ventures Janssen

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.